NCT03977766

Feasibility of a Process of Digital Validation of Chemotherapies in a Day Treatment Unit

Feasibility of a Process of Digital Validation of Outpatients Chemotherapies in a Day Treatment Unit

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Institut Paoli-Calmettes · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The aim of CPV 2.0 study is to evaluate a process of digital prevalidation of outpatients chemotherapy thanks to a numeric application. This digital tool is based on the combination of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to a decisional algorithm. After cycle 1, chemotherapy digital prevalidation will be done with the help of a nurse for two consecutive cycles (cycles 2 and 3). Patients will then have to use to application by themselves for the two following cycles (cycles 4 and 5)

Conditions

• Solid Tumor, Adult

Interventions

Type	Name	Description
PROCEDURE	Chemotherapy prevalidation	Outpatient Chemotherapy prevalidation will done * with the help of a nurse, using the digital application, for cycle 2 and 3. * by the patient alone, using the digital application, for cycle 4 and 5.

Timeline

• Start date: 2019-10-15
• Primary completion: 2021-04-15
• Completion: 2021-04-15
• First posted: 2019-06-06
• Last updated: 2019-06-06